Abeona Therapeutics Inc. (ABEO)

$6.74 3.37% $0.22 Healthcare

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

$291.94M

Dr. Vishwas Seshadri M.B.A., Ph.D.

90.00

New York, NY

Sep 19, 1980

-3.83

$-1.76

2.04

7.48

-1,862.57%

-4.96

-0.53

3.56

100.00

7.48

-39.25%

-207.85%

Similar stocks (18)

ACADIA Pharmaceuticals Inc.

ACAD

$15.17 0.86%
Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$15.08 0.47%
Neutral

Terns Pharmaceuticals, Inc.

TERN

$7.50 -1.96%
Neutral

REGENXBIO Inc.

RGNX

$10.60 -1.40%
Downtrend

Inozyme Pharma, Inc.

INZY

$5.15 -3.01%
Downtrend

Cabaletta Bio, Inc.

CABA

$4.85 4.08%
Downtrend

Black Diamond Therapeutics, Inc.

BDTX

$3.22 -5.29%
Downtrend

Checkpoint Therapeutics, Inc.

CKPT

$2.97 5.32%
Uptrend

Invivyd, Inc.

IVVD

$1.05 6.52%
Downtrend

PDS Biotechnology Corporation

PDSB

$3.10 -2.21%
Downtrend

Leap Therapeutics, Inc.

LPTX

$2.33 -2.92%
Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.50 -6.81%
Downtrend

Fortress Biotech, Inc.

FBIO

$1.81 3.43%
Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$1.83 -3.17%
Downtrend

Reviva Pharmaceuticals Holdings, Inc.

RVPH

$1.28 4.06%
Downtrend

Pieris Pharmaceuticals, Inc.

PIRS

$16.93 2.86%
Neutral

Athira Pharma, Inc.

ATHA

$0.45 -1.52%
Downtrend

Calithera Biosciences, Inc.

CALA

$0.00 0.00%
Downtrend